SMS Pharmaceuticals Limited (SMSPHARMA) Price & Analysis

Compare

2 Followers

SMSPHARMA Stock Chart & Stats

₹325.40

-₹5.32(-2.16%)

At close: Jan 08 4:00 PM EST

₹325.40

-₹5.32(-2.16%)

Day’s Range― - ―

52-Week Range₹175.00 - ₹387.00

Previous CloseN/A

Volume71.57K

Average Volume (3M)105.50K

Market Cap

₹34.63B

Enterprise Value₹37.13B

Total Cash (Recent Filing)₹415.86M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)37.2

Beta1.66

Next Earnings

Jun 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.13%

Share Statistics

EPS (TTM)2.51

Shares Outstanding93,652,030

10 Day Avg. Volume15,241

30 Day Avg. Volume105,503

Financial Highlights & Ratios

PEG Ratio0.70

Price to Book (P/B)2.91

Price to Sales (P/S)2.38

P/FCF Ratio-31.61

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained revenue growth across multiple years indicates expanding product uptake and market penetration in APIs. Over 2–6 months this underpins capacity utilization, supports margin recovery through scale, and provides management room to invest in R&D or capacity to capture long‑term demand.

Stable Balance-sheet BackingA moderate leverage profile with relatively strong equity backing offers financial resilience versus cyclical shocks. This durable stability supports capital spending, supplier relationships and the ability to pursue strategic opportunities without immediate refinancing pressure over the medium term.

API Manufacturing Business ModelSupplying APIs to formulators across domestic and export markets is structurally defensive: long qualification cycles, regulatory barriers and sticky supply relationships create durable demand and switching costs, supporting predictable revenue streams and repeat business.

Bears Say

Volatile Cash GenerationInconsistent free cash flow constrains reinvestment, deleveraging and shareholder returns. Over a medium horizon this volatility can force higher reliance on external funding for capex or working capital, raising execution and financing risk for expansion plans.

Net Income Volatility / 2023 LossA material net income drop and a negative margin year signal underlying cost, pricing or operational issues. Persisting volatility undermines sustainable profitability, weakens return metrics like ROE, and complicates long‑term planning and investor confidence.

Rising Debt Requires MonitoringAn upward trend in debt raises interest and refinancing exposure. If continued amid cash‑flow variability it can limit strategic flexibility, increase fixed charges and elevate solvency risk over a multi‑quarter horizon, particularly if margins remain pressured.

SMS Pharmaceuticals Limited News

SMS Pharmaceuticals Sets Up Wholly Owned Subsidiary SMS coLab for Greenfield Pharma Expansion

The latest update is out from SMS Pharmaceuticals Limited ( ($IN:SMSPHARMA) ). SMS Pharmaceuticals Limited has incorporated a...

2M ago

SMS Pharmaceuticals Completes Successful USFDA Inspection at Vizag Facility

SMS Pharmaceuticals Limited ( ($IN:SMSPHARMA) ) has provided an announcement. SMS Pharmaceuticals Limited announced the successful completion of...

2M ago

SMS Pharmaceuticals’ Credit Rating Upgraded by CARE Ratings

SMS Pharmaceuticals Limited ( ($IN:SMSPHARMA) ) has shared an update. SMS Pharmaceuticals Limited announced that CARE Ratings Limited...

3M ago

SMS Pharmaceuticals Reports Strong Q1 Financial Performance

SMS Pharmaceuticals Limited ( ($IN:SMSPHARMA) ) has issued an announcement. SMS Pharmaceuticals Limited reported a strong financial performance...

7M ago

SMS Pharmaceuticals Releases Q1 FY26 Investor Presentation

An announcement from SMS Pharmaceuticals Limited ( ($IN:SMSPHARMA) ) is now available. SMS Pharmaceuticals Limited has released its...

7M ago

SMS Pharmaceuticals Transfers Shares to IEPF for Unclaimed Dividends

An announcement from SMS Pharmaceuticals Limited ( ($IN:SMSPHARMA) ) is now available. SMS Pharmaceuticals Limited announced the transfer...

8M ago

SMSPHARMA FAQ

What was SMS Pharmaceuticals Limited’s price range in the past 12 months?

SMS Pharmaceuticals Limited lowest stock price was ₹175.00 and its highest was ₹387.00 in the past 12 months.

What is SMS Pharmaceuticals Limited’s market cap?

SMS Pharmaceuticals Limited’s market cap is ₹34.63B.

When is SMS Pharmaceuticals Limited’s upcoming earnings report date?

SMS Pharmaceuticals Limited’s upcoming earnings report date is Jun 03, 2026 which is in 100 days.

How were SMS Pharmaceuticals Limited’s earnings last quarter?

SMS Pharmaceuticals Limited released its earnings results on Feb 07, 2026. The company reported ₹2.506 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.506.

Is SMS Pharmaceuticals Limited overvalued?

According to Wall Street analysts SMS Pharmaceuticals Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does SMS Pharmaceuticals Limited pay dividends?

SMS Pharmaceuticals Limited pays a Annually dividend of ₹0.4 which represents an annual dividend yield of 0.13%. See more information on SMS Pharmaceuticals Limited dividends here

What is SMS Pharmaceuticals Limited’s EPS estimate?

SMS Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does SMS Pharmaceuticals Limited have?

SMS Pharmaceuticals Limited has 93,652,030 shares outstanding.

What happened to SMS Pharmaceuticals Limited’s price movement after its last earnings report?

SMS Pharmaceuticals Limited reported an EPS of ₹2.506 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.745%.

Which hedge fund is a major shareholder of SMS Pharmaceuticals Limited?

Currently, no hedge funds are holding shares in IN:SMSPHARMA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.